What is the half-life of CJC-1295 with DAC?

CJC-1295 with DAC has an approximate elimination half-life of 7.0 d. Long-acting — weekly dosing keeps levels steady.

How long does CJC-1295 with DAC stay in your system?

Roughly 97% of a dose has cleared after five half-lives — about ~5 weeks for CJC-1295 with DAC. That is the window that matters for washouts, bloodwork and surgery.

How is CJC-1295 with DAC taken?

CJC-1295 with DAC is typically administered by the subcutaneous route. Research range: 1–2 mg subcutaneous once weekly. Often stacked with Ipamorelin.

What are the risks of CJC-1295 with DAC?

Sustained GH elevation can cause water retention, joint aches, glucose changes Not pulsatile — diverges from natural GH rhythm Avoid with diabetes, sleep apnea, or hormone-sensitive conditions

CJC-1295 with DAC

cjc dac

Long-acting GHRH analog via Drug Affinity Complex. Weekly dosing rationale, sleep and recovery tracking.

Half-life: 7.0 d
Out of system: ~5 weeks
Route: Subcutaneous
Level: Intermediate

Long-acting — weekly dosing keeps levels steady. After the last dose, roughly 97% has cleared in ~5 weeks (five half-lives) — the window that matters for washouts, bloodwork and surgery.

What CJC-1295 with DAC is used for

Long-acting GHRH analog — sustained baseline GH lift
Weekly dosing instead of daily injections
Reported sleep and recovery improvements

How it's typically used

Research range: 1–2 mg subcutaneous once weekly. Often stacked with Ipamorelin.

What to watch for

Sustained GH elevation can cause water retention, joint aches, glucose changes
Not pulsatile — diverges from natural GH rhythm
Avoid with diabetes, sleep apnea, or hormone-sensitive conditions

Common questions

What is the half-life of CJC-1295 with DAC?: CJC-1295 with DAC has an approximate elimination half-life of 7.0 d. Long-acting — weekly dosing keeps levels steady.
How long does CJC-1295 with DAC stay in your system?: Roughly 97% of a dose has cleared after five half-lives — about ~5 weeks for CJC-1295 with DAC. That is the window that matters for washouts, bloodwork and surgery.
How is CJC-1295 with DAC taken?: CJC-1295 with DAC is typically administered by the subcutaneous route. Research range: 1–2 mg subcutaneous once weekly. Often stacked with Ipamorelin.
What are the risks of CJC-1295 with DAC?: Sustained GH elevation can cause water retention, joint aches, glucose changes Not pulsatile — diverges from natural GH rhythm Avoid with diabetes, sleep apnea, or hormone-sensitive conditions

About Performance & GH

What they are: Growth-hormone secretagogues and related performance compounds. Rather than supplying GH, they push your pituitary to release more of its own in a pulse.
How they're run: Subcutaneous injection, most often at night on an empty stomach so the pulse lands with natural sleep-driven GH release.
What to watch: Water retention, tingling hands, and hunger swings are the common early signs. Raising GH raises IGF-1 — worth tracking on bloodwork, and a reason to avoid these with any cancer history.

Full guide

CJC-1295 with DAC: Tracking the Long-Acting GHRH Analog

A practical tracking guide for the DAC version of CJC-1295, with weekly dosing rationale and IGF-1 expectations.

Other performance & gh

Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.